Market Cap

GlaxoSmithKline plc Market Capitalization:

£56.92 Billion

GBP as of July 1, 2023

US$72.32 Billion

business GlaxoSmithKline plc Company Profile

GlaxoSmithKline plc Main Stock Listing

show_chart LSE: GSK

Market Capitalization History of GlaxoSmithKline plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly evolution of GlaxoSmithKline plc market cap

Date Market Cap YoY Change
Jan. 1, 2023 £73.90 B -12.04%
Jan. 1, 2022 £84.01 B 21.08%
Jan. 1, 2021 £69.39 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Company Description

GlaxoSmithKline PLC, better known as GSK, is a pharmaceutical company. GSK manufactures products for major disease areas such as asthma, cancer, infections, diabetes, and mental health, and it also has a portfolio of vaccines. Operating in more than 115 countries, GSK is also engaged in the consumer healthcare business in oral health, pain relief, respiratory, nutrition/gastro-intestinal, and skin health categories.

business GlaxoSmithKline plc Company Profile

Stocks & Indices

GlaxoSmithKline plc has the following listings and related stock indices.

Stock: LSE: GSK

Stock: BCBA: GSK

Stock: BMV: GSKN

Stock: FSX: GS7


Stock: XETR: GS7

Stock: NYSE: GSK

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.